Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
| Actual shortage: | 236 (8%) | |
| Anticipated shortage: | 18 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2023-03-09 | 2023-04-14 | 186586 |
| APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-02-23 | 216699 |
| APO-QUETIAPINE FUMARATE | 100MG | TABLET (IMMEDIATE RELEASE) | Anticipated shortage | 2024-01-19 | 2024-02-06 | 216702 |
| APO-QUETIAPINE FUMARATE | 200MG | TABLET (IMMEDIATE RELEASE) | Anticipated shortage | 2024-01-19 | 2024-02-06 | 216705 |
| APO-QUETIAPINE FUMARATE | 300MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-02-23 | 216708 |
| APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-09 | 2020-11-03 | 66543 |
| APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-30 | 2020-11-03 | 74033 |
| APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-24 | 2020-11-03 | 76735 |
| APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-24 | 2020-11-03 | 76740 |
| APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156543 |
| APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156546 |
| APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-03-11 | 2022-04-06 | 156549 |
| APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-09 | 2022-12-16 | 177672 |
| APO-QUETIAPINE XR | 150MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-12-08 | 2024-01-19 | 212969 |
| APO-QUETIAPINE XR | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-03-22 | 216687 |
| APO-QUETIAPINE XR | 200MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-03-05 | 216690 |
| APO-QUETIAPINE XR | 300MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-04-23 | 216693 |
| APO-QUETIAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-19 | 2024-04-19 | 216696 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-02 | 453 |
| APO-QUINAPRIL | 10MG | TABLET | Resolved | 2017-03-11 | 2017-06-05 | 463 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
| APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
| APO PREDNISONE TAB 1MG USP | 1MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1056 |
| APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
| APO TRIAZIDE | 50MG 25MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60837 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-ACEBUTOLOL | 400MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4965 |
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-09-08 | 60157 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2018-09-07 | 2019-12-20 | 60163 |
| APO-ALENDRONATE | 5MG | TABLET | Discontinued | 2019-01-03 | 2019-12-21 | 71023 |
| APO-ALENDRONATE | 10MG | TABLET | To be discontinued | 2019-01-03 | 2019-12-20 | 71026 |
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
| APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
| APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-AMOXI | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2019-02-13 | 60171 |
| APO-AMOXI | 500MG | CAPSULE | Discontinued | 2018-09-07 | 2018-11-09 | 60174 |
| APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |